$AME

Ametek beats top-line and bottom-line estimates; gives Q4 and updates FY26 outlook

Ametek (AME) reported Q3 Non-GAAP EPS of $2.21, exceeding estimates by $0.10, with revenue of $2.22B, up 17.5% year-over-year. The company raised its 2026 sales growth outlook to mid-teens from 14.17% year-over-year.

Original reporting
Published Nov 3, 2026, 11:58 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 12:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$AME
Bullish
medium confidence
Mentioned
$AME
Relevance
9/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$AMEBullishMed
01

Why it matters

The combination of EPS and revenue beats with an updated FY26 sales growth expectation is a direct catalyst for forward estimates and near-term positioning.

02

Market read

This is a company-specific earnings and guidance update that can drive same-day estimate revisions and trading in AME.

03

What to watch

Traders may focus on segment margin trajectory and order trends, which are not included in the scraped excerpt, so the market reaction could hinge on details beyond the beats and headline outlook.

Relevance 9/10Novelty 8/10Timing: as of the Q3 earnings release day, with Q4 and FY26 outlook updates

Background

The piece summarizes Ametek’s Q3 results and provides updated Q4 and FY26 outlook language from the company’s press release.

Company-level read

Ticker impact

$AMEBullishMedium confidence
Context

Ametek reported Q3 non-GAAP EPS of $2.21 and revenue of $2.22B, both beating estimates, and updated Q4 and FY26 outlook.

Expected impact

Likely positive bias as the market adjusts to the company’s raised/updated FY26 growth and Q4 guidance.

Evidence & confidence

The article includes specific Q3 beat figures and a new FY26 sales growth expectation, which are direct inputs to forward valuation and positioning.

Market effects

Industrial instrumentation and electronics demand expectations may get a modest positive read-through if peers use AME’s guidance as a reference point.

Primarily US large-cap industrial sentiment; limited direct regional spillover beyond US trading desks.

Global industrial demand sentiment could be marginally supported, but the impact is mostly company-specific.

Counterpoint

A guidance update can be less bullish if the updated FY26 growth rate is only modest versus what the market already priced in.

Key entities

  • Ametek

    Industrial technology company reporting Q3 results and updating Q4 and FY26 outlook.

Related articles

$AMEHighAI 9/10

AMETEK Posts Record Q3 Sales and Adjusted EPS, Raises 2026 Guidance

AMETEK reported Q3 2026 sales of $2.22B, up 17% YoY, and adjusted EPS of $2.21. GAAP EPS was $1.85, with net income at $426.3M. The company raised its full-year adjusted EPS outlook to $8.53–$8.57. Growth was driven by organic sales, acquisitions, and strong demand across its businesses. AMETEK also completed the acquisition of Indicor Instrumentation.

$AMEHighAI 9/10

AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance

AMETEK INC/ (AME) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance Berwyn, Pa., Nov 3, 2026 – AMETEK, Inc. (NYSE: AME) today announced its financial results for the third quarter ended September 30, 2026. AMETEK’s third quarter 2026 sales were a record

$AMEMedAI 8/10

AMETEK Boosts FY26 Outlook - Update

AMETEK (AME) reported Q3 results and raised its FY26 outlook. Q4 adjusted earnings are expected to be $2.26-$2.30 per share with net sales growth in the low 20% range. FY26 adjusted earnings are now projected to be $8.53-$8.57 per share with mid-teen percentage net sales growth, up from previous guidance of $8.20-$8.30 per share. AME stock is up 0.86% in pre-market trading.

$AMEMedAI 9/10

AMETEK’s (NYSE:AME) Q3 2026 sales beat estimates

AMETEK reported Q3 2026 revenue of $2.22 billion, exceeding estimates by 2.9% and growing 17.3% year-on-year. Adjusted EPS was $2.21, beating estimates by 4.8%. Management raised full-year adjusted EPS guidance to $8.55 at the midpoint, a 3.6% increase. Operating margin remained steady at 26.3%, while free cash flow margin improved to 23.8% from 22.2% year-on-year.